Menu

Allyson C. Spacht is a partner who advises foreign and domestic insurance carriers on a variety of complex disputes involving commercial general liability, professional liability, and excess/umbrella exposures. Allyson is an integral member of BatesCarey’s Opioid Coverage Task Force, through which she participates in monitoring, analyzing, and litigating cutting edge insurance coverage issues related to opioid lawsuits filed nationwide against pharmaceutical manufacturers, distributors, and retail pharmacies. In addition, Allyson advises foreign and domestic carriers in connection with climate change risks, including insurance coverage issues implicated by the nationwide climate change litigation filed against the fossil fuel supply chain.

Allyson also has experience representing corporate clients in all aspects of complex commercial litigation matters in federal and state courts at both the trial and appellate levels. Her experience has included product liability and tort litigation, antitrust defense, contract disputes, and deceptive trade practice disputes. Allyson also has experience conducting investigations, counseling clients, and defending lawsuits for healthcare and pharmaceutical clients on a variety of issues, including the anti-kickback statute, pricing rules, and the False Claims Act.

Allyson’s insurance work has been highly regarded by both clients and peers alike, earning her recognition by The Best Lawyers in America in their "Ones to Watch" list.

Allyson previously served as a judicial law clerk to the Honorable Philip P. Simon in the United States District Court for the Northern District of Indiana.

Representative Matters

In re CVS Opioid Ins. Litig., No. N22C-02-045, 2023 WL 6059801 (Del. Super. Ct. Aug. 25, 2023), as corrected (Sept. 14, 2023) Obtained summary judgment ruling in coordination with other commercial general liability insurers that opioid lawsuits seeking to recover generalized economic losses suffered by governmental entities to abate the opioid crisis do not seek damages “because of” “bodily injury” or “property damage.”

Publications

"Liability Insurance Outlook For Opioid Public Nuisance Claims" Law 360 Insurance, Expert Analysis (April 22, 2020)

"Can America’s Opioid Epidemic Squeeze into Tort or Insurance Law?" For the Defense (December 2019)

“What does the $572 million Oklahoma opioid judgment mean for other opioid defendants and insurers?” Advisen Front Page News (September 3, 2019)